Hypertrophic cardiomyopathy: individualized therapy for a heterogeneous disease.
It is now 50 years since the modern description of hypertrophic cardiomyopathy (HCM). The initial descriptions foretold the current efforts towards sudden death prevention, alleviation of heart failure symptoms and angina, relief of left ventricular outflow tract obstruction, preparticipation athletic screening, family screening and genetic testing. The authors review the salient features of HCM, focusing on therapeutic strategies to manage its symptoms and attempts to prevent sudden death.
Sherrid
M V
MV
Hypertrophic Cardiomyopathy Program and the Echocardiography Laboratory Division of Cardiology, Department of Medicine St. Luke's, Roosevelt Hospital Center Columbia University College of Physicians and Surgeons New York City, NY, USA. msherrid@chpnet.org
Sirak
T
T
D006348:Cardiac Surgical Procedures / Q000379:methods; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications / Q000175:diagnosis / Q000235:genetics / Q000601:surgery / Q000628:therapy*; D003663:Decision Trees; D000431:Ethanol / Q000008:administration & dosage; D006801:Humans; D010808:Physical Examination
D000431:Ethanol